phthalimide has been researched along with Acute Confusional Senile Dementia in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amanlou, M; Asadi, M; Azizian, H; Biglar, M; Ebrahimi, M; Edraki, N; Larijani, B; Mahdavi, M; Mirzazadeh, R; Mohammadi-Khanaposhtani, M; Nadri, H; Sepehri, S | 1 |
| Cao, Z; Deng, Y; Liu, X; Qiang, X; Song, Q; Yu, G; Zhang, H | 1 |
| Petzer, A; Petzer, JP; Terre'Blanche, G; Van der Walt, MM | 1 |
| Bajda, M; Godyń, J; Hebda, M; Malawska, B; Więckowska, A; Więckowski, K | 1 |
| Cui, MC; Duan, XH; Liu, BL; Qiao, JP; Yang, Y; Zhou, JN | 1 |
5 other study(ies) available for phthalimide and Acute Confusional Senile Dementia
| Article | Year |
|---|---|
Design, Synthesis, Molecular Docking, and Cholinesterase Inhibitory Potential of Phthalimide-Dithiocarbamate Hybrids as New Agents for Treatment of Alzheimer's Disease.
Topics: Acetylcholinesterase; Alzheimer Disease; Amyloid Precursor Protein Secretases; Animals; Aspartic Acid Endopeptidases; Butyrylcholinesterase; Drug Design; Electrophorus; Enzyme Inhibitors; Horses; Humans; Molecular Docking Simulation; Molecular Dynamics Simulation; Molecular Structure; Phthalimides; Thiocarbamates | 2019 |
Phthalimide-(N-alkylbenzylamine) cysteamide hybrids as multifunctional agents against Alzheimer's disease: Design, synthesis, and biological evaluation.
Topics: Acetylcholinesterase; Alzheimer Disease; Animals; Antioxidants; Benzylamines; Blood-Brain Barrier; Cholinesterase Inhibitors; Cysteamine; Drug Design; Humans; Molecular Docking Simulation; Neuroprotective Agents; PC12 Cells; Phthalimides; Protein Binding; Rats; Structure-Activity Relationship | 2021 |
The adenosine receptor affinities and monoamine oxidase B inhibitory properties of sulfanylphthalimide analogues.
Topics: Alzheimer Disease; Humans; Models, Molecular; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Parkinson Disease; Phthalimides; Purinergic P1 Receptor Antagonists; Receptors, Purinergic P1; Structure-Activity Relationship | 2015 |
Lipophilic properties of anti-Alzheimer's agents determined by micellar electrokinetic chromatography and reversed-phase thin-layer chromatography.
Topics: Alzheimer Disease; Cholinesterase Inhibitors; Chromatography, Micellar Electrokinetic Capillary; Chromatography, Reverse-Phase; Chromatography, Thin Layer; Drug Discovery; Humans; Hydrophobic and Hydrophilic Interactions; Indoles; Lipids; Phthalimides; Tetrahydroisoquinolines | 2017 |
Novel anilinophthalimide derivatives as potential probes for beta-amyloid plaque in the brain.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Aniline Compounds; Animals; Brain; Humans; Mice; Phthalimides; Tomography, Emission-Computed, Single-Photon | 2010 |